Should We Bury HbA1c?

Rahbar S . An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta, 1968; 22(2):296–298; doi: 10.1016/0009-8981(68)90372-0

Koenig RJ , Peterson CM , Jones RL , et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med, 1976; 295(8):417–420; doi: 10.1056/NEJM197608192950804

Nathan DM . DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care, 2014; 37(1):9–16; doi: 10.2337/dc13-2112

Hempe JE , Gomez R , McCarter RJ , et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control. J Diabetes Complications, 2002; 16(5):313–320; doi: 10.1016/s1056-8727(01)00227-6

Borg R , Kuenen JC , Carstensen B , et al. ADAG Study Group. Associations between features of glucose exposure and A1C: The A1C-Derived Average Glucose (ADAG) study. Diabetes, 2010; 59(7):1585–1590; doi: 10.2337/db09-1774

Bergenstal RM , Beck RW , Close KL , et al. Glucose Management Indicator (GMI): A new term for estimating A1C from continuous glucose monitoring. Diabetes Care, 2018; 41(11):2275–2280; doi: 10.2337/dc18-1581

Perlman JE , Gooley TA , McNulty B , et al. HbA1c and glucose management indicator discordance: A real-world analysis. Diabetes Technol Ther, 2021; 23(4):253–258; doi: 10.1089/dia.2020.0501

Hempe JM , Liu S , Myers L , et al; The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD Trial. Diabetes Care, 2015; 38(6):1067–1074; doi: 10.2337/dc14-1844

Selvin E . Hemoglobin A_1c -using epidemiology to guide medical practice: Kelly West Award Lecture 2020. Diabetes Care, 2021; 44(10):2197–2204; doi: 10.2337/dci21-0035

Lu J , Home PD , Zhou J . Comparison of multiple cut points for time in range in relation to risk of abnormal carotid intima-media thickness and diabetic retinopathy. Diabetes Care, 2020; 43(8):e99–e101; doi: 10.2337/dc20-0561

Lu J , Ma X , Zhou J , et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care, 2018; 41(11):2370–2376; doi: 10.2337/dc18-1131

Wakasugi S , Mita T , Katakami N , et al. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Res Care, 2021; 9(1):e001923; doi: 10.1136/bmjdrc-2020-001923

Wang Y , Lu J , Shen Y , et al. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients. J Diabetes Investig, 2022; 13(9):1543–1550; doi: 10.1111/jdi.13811

Beck RW , Bergenstal RM , Riddlesworth TD , et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care, 2019; 42(3):400–405; doi: 10.2337/dc18-1444

Lagotte A . Is CGM Technology the Best Kept Secret in Diabetes. Available from: https://onedrop.today/blogs/blog/bgm-vs-cgm [Last accessed: December 9, 2023 ].

Isaacs D , Bellini NJ , Biba U , et al. Health care disparities in use of continuous glucose monitoring. Diabetes Technol Ther, 2021; 23(S3):S81–S87; doi: 10.1089/dia.2021.0268

American Diabetes Association. Health Equity and Diabetes Technology: A Study of Access to Continuous Glucose Monitors by Payer, Geography and Race Executive Summary. [White Paper]; September 2023. Available from: https://diabetes.org/sites/default/files/2023-09/ADA-CGM-Utilization-White-Paper-Oct-2022.pdf [Last accessed: December 6, 2023 ].

Center for Healthcare Strategies: Continuous Glucose Monitoring Access for Medicaid Beneficiaries Living with Diabetes: State by State Coverage. [White Paper]; 2023. Available from: https://www.chcs.org/media/CGM-Access-for-Medicaid-Beneficiaries-Living-with-Diabetes-State-By-State-Coverage.pdf [Last accessed: December 9, 2023 ].

Alzahrani BA , Salamatullah HK , Alsharm FS , et al. The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocr Disord, 2023; 23(1):24; doi: 10.1186/s12902-023-01280-y

Panzer S , Kronik G , Lechner K , et al. Glycosylated hemoglobins (GHb): An index of red cell survival. Blood, 1982; 59(6):1348–1350.

Welsh KJ , Kirkman MS , Sacks DB . Role of glycated proteins in the diagnosis and management of diabetes: Research gaps and future directions. Diabetes Care, 2016; 39(8):1299–1306; doi: 10.2337/dc15-2727

Arakaki RF , Changcharoen B . Glycemic assessment in patients with Hemoglobin Leiden and type 2 diabetes. AACE Clin Case Rep, 2016; 2:e307–e310; doi: 10.4158/EP151004.CR

Lacy ME , Wellenius GA , Sumner AE , et al. Association of sickle cell trait with hemoglobin A1c in African Americans. JAMA, 2017; 317(5):507–515; doi: 10.1001/jama.2016.21035

Brodeur MT , Sutherland DW , Koler RD , et al. Red blood cell survival in patients with aortic valvular disease and ball-valve prostheses. Circulation, 1965; 32(4):570–581; doi: 10.1161/01.cir.32.4.570

Dello Russo P , Ceriello A , Curcio F . Reticulocyte counts and haemoglobin glycosylation in diabetes. Diabete Metab, 1984; 10(4):277–278.

McCready F , Cundy T . Effects of splenectomy for hereditary spherocytosis on glycated haemoglobin in a woman with type 2 diabetes. Diabet Med, 2009; 26(5):570–571; doi: 10.1111/j.1464-5491.2009.02706.x

Galindo RJ , Beck RW , Scioscia MF , et al. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev, 2020; 41(5):756–774; doi: 10.1210/endrev/bnaa017

Ng MJ , Cooke M , Bhandari S , et al. The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care, 2010; 33(11):2310–2313; doi: 10.2337/dc10-0917

Peacock TP , Shihabi ZK , Bleyer AJ , et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int, 2008; 73(9):1062–1068; doi: 10.1038/ki.2008.25.n

Nishida T . Diagnosis and clinical implications of diabetes in liver cirrhosis: A focus on the Oral Glucose Tolerance Test. J Endocr Soc, 2017; 1(7):886–896; doi: 10.1210/js.2017-00183

Lurquin F , Buysschaert M , Preumont V . Advances in cystic fibrosis-related diabetes: Current status and future directions. Diabetes Metab Syndr, 2023; 17(11):102899; doi: 10.1016/j.dsx.2023.102899

Godbout AJ , Hammana I , Potvin S , et al. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab, 2008; 34(6 Pt 1):568–573; doi: 10.1016/j.diabet.2008.05.010

Kim MK , Kwon HS , Baek KH , et al. Effects of thyroid hormone on A1C and glycated albumin levels in nondiabetic subjects with overt hypothyroidism. Diabetes Care, 2010; 33(12):2546–2548; doi: 10.2337/dc10-0988

Unnikrishnan R , Anjana RM , Mohan V . Drugs affecting HbA1c levels. Indian J Endocrinol Metab, 2012; 16(4):528–531; doi: 10.4103/22300-8210.98004

Diop ME , Bastard JP , Meunier N , et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses, 2006; 22(12):1242–1247; doi: 10.1089/aid.2006.22.1242

Kim PS , Woods C , Georgoff P , et al. A1C underestimates glycemia in HIV infection. Diabetes Care, 2009; 32(9):1591–1593; doi: 10.2337/dc09-0177

Mitchell K , Mukhopadhyay B . Drug-induced falsely low A1C: Report of a case series from a Diabetes Clinic. Clin Diabetes, 2018; 36(1):80–84; doi: 10.2337/cd17-0005

Robertson M . Artificially low HbA1c associated with treatment with ribavirin. BMJ, 2008; 336(7642):505.

Greenberg PD , Rosman AS , Eldeiry LS , et al. Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. J Viral Hepat, 2006; 13(9):613–617; doi: 10.1111/j.1365-2893.2006.00729.x

Polgreen PM , Putz D , Stapleton JT . Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis, 2003; 37(4):e53–e56; doi: 10.1086/376633

Nakao T , Matsumoto H , Okada T , et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med, 1998; 37(10):826–830; doi: 10.2169/internalmedicine.37.826

AlQarni AM , Alghamdi AA , Aljubran HJ , et al. The effect of iron replacement therapy on HbA1c levels in diabetic and nondiabetic patients: A systematic review and meta-analysis. J Clin Med, 2023; 24;12(23):7287; doi: 10.3390/jcm12237287

Kumari K , Kumar R , Memon A , et al. Treatment with testosterone therapy in type 2 diabetic hypogonadal adult males: A systematic review and meta-analysis. Clin Pract, 2023; 13(2):454–469; doi: 10.3390/clinpract13020041

American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: Standards of Care in Diabetes-2024. Diabetes Care, 2024; 47(Suppl 1):S282–S294; doi: 10.2337/dc24-S015

Nielsen LR , Ekbom P , Damm P , et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care, 2004; 27(5):1200–1201; doi: 10.2337/diacare.27.5.1200.P

Camargo JL , Stifft J , Gross JL . The effect of aspirin and vitamins C and E on HbA1c assays. Clin Chim Acta, 2006; 372(1–2):206–209; doi: 10.1016/j.cca.2006.03.031

Ceriello A , Giugliano D , Dello Russo P , et al. Increased glycosylated haemoglobin A1c in opiate addicts: Evidence for hyperglycaemic effect of morphine. Diabetologia, 1982; 22:379.

English E , Idris I , Smith G , et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: A systematic review. Diabetologia, 2015; 58(7):1409–1421; doi: 10.1007/s00125-015-3599-3

Coban E , Ozdogan M , Timuragaoglu A . Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol, 2004; 112(3):126–128; doi: 10.1159/000079722

Gram-Hansen P , Eriksen J , Mourits-Andersen T , et al. Glycosylated haemoglobin (HbA1c) in iron- and vitamin B12 deficiency. J Intern Med, 1990; 227(2):133–136; doi: 10.1111/j.1365-2796.1990.tb00131

Veeranna V , Zalawadiya SK , Panaich SS , et al. The association of red cell distribution width with glycated hemoglobin among healthy adults without diabetes mellitus. Cardiology, 2012; 122(2):129–132; doi: 10.1159/000339225

Bae JC , Suh S , Jin SM , et al. Hemoglobin A1c values are affected by hemoglobin level and gender in non-anemic Koreans. J Diabetes Investig, 2014; 5(1):60–65; doi: 10.1111/jdi.12123

Ao X , Ganta N , Choe S , et al. Hemoglobin Wayne: A rare variant that can cause falsely elevated hemoglobin A1c. Cureus, 2022; 14(7):e26559; doi: 10.7759/cureus.26559

Hoberman HD , Chiodo SM . Elevation of the hemoglobin A1 fraction in alcoholism. Alcohol Clin Exp Res, 1982; 6(2):260–266; doi: 10.1111/j.1530-0277.1982.tb04972.x

Chang CW , Wang CW , Wu DW , et al. Significant association between blood lead (Pb) level and haemoglobin A1c in non-diabetic population. Diabetes Metab, 2021; 47(5):101233; doi: 10.1016/j.diabet.2021.101233

Pani LN , Korenda L , Meigs JB , et al. Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care, 2008; 31(10):1991–1996; doi: 10.2337/dc08-0577

Masuch A , Friedrich N , Roth J , et al. Preventing misdiagnosis of diabetes in the elderly: Age-dependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord, 2019; 19(1):20; doi: 10.1186/s12902-019-0338-7

Hashimoto K , Osugi T , Noguchi S , et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care, 2010; 33(3):509–511; doi: 10.2337/dc09-1954

NGSP. Factors that Interfere with HbA1C. Available from: https://ngsp.org/factors.asp [Last accessed: January 10, 2024 ].

Falko JM , O'Dorisio TM , Cataland S . Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med, 1982; 142(7):1370–1371.

Vlassopoulos A , Lean ME , Combet E . Influence of smoking and diet on glycated haemoglobin and ‘pre-diabetes' categorisation: A cross-sectional analysis. BMC Public Health, 2013; 13:1013; doi: 10.1186/1471-2458-13-1013

Karter AJ , Parker MM , Moffet HH , et al. Racial and ethnic differences in the association between mean glucose and hemoglobin A1c. Diabetes Technol Ther, 2023; 25(10):697–704; doi: 10.1089/dia.2023.0153

Cavagnolli G , Pimentel AL , Freitas PA , et al. Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. PLoS One, 2017; 12(2):e0171315; doi: 10.1371/journal.pone.0171315

Bergenstal RM , Gal RL , Connor CG , et al.; T1D Exchange Racial Differences Study Group. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med, 2017; 18;167(2):95–102; doi: 10.7326/M16-2596

Weykamp C , Kemna E , Leppink S , et al. Glycation rate of haemoglobins S, C, D, E, J and G, and analytical interference on the measurement of HbA_1c with affinity chromatography and capillary electrophoresis. Clin Chem Lab Med, 2015; 53(9):e207–e210; doi: 10.1515/cclm-2014-1134

Fantasia KL , Wirunsawanya K , Lee C , et al. Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a Safety-Net Hospital. J Diabetes Sci Technol, 2021; 15(5):1010–1017; doi: 10.1177/1932296821995810

Lai CS , Lipman TH , Willi SM , et al. Racial and ethnic disparities in rates of continuous glucose monitor initiation and continued use in children with type 1 diabetes. Diabetes Care, 2021; 44:255–257; doi: 10.2337/dc20-1663

Oser TK , Hall TL , Dickinson LM , et al. Continuous glucose monitoring in primary care: Understanding and supporting clinicians' use to enhance diabetes care. Ann Fam Med, 2022; 20(6):541–547; doi: 10.1370/afm.2876

Schmitt J , Fogle K , Scott ML , et al. Improving equitable access to continuous glucose monitors for Alabama's children with type 1 diabetes: A Quality Improvement Project. Diabetes Technol Ther, 2022; 24(7):481–491; doi: 10.1089/dia.2021.0511

Mathias P , Mahali LP , Agarwal S . Targeting technology in underserved adults with type 1 diabetes: Effect of diabetes practice transformations on improving equity in CGM Prescribing Behaviors. Diabetes Care, 2022; 45(10):2231–2237; doi: 10.2337/dc22-0555

Bovee LB , Perlman JE , Gooley T , et al. Association of Diabetic Retinopathy with Hemoglobin A1C and Glucose Management Indicator (GMI) Discordance. American Diabetes Association 83rd Scientific Sessions. June 23, 2023. San Diego, California.

Ibarra-Salce R , Pozos-Varela FJ , Martinez-Zavala N , et al. Correlation between hemoglobin glycation index measured by continuous glucose monitoring with complications in type 1 diabetes. Endocr Pract, 2023; 29(3):162–167; doi: 10.1016/j.eprac.2023.01.001

Sakane N , Hirota Y , Yamamoto A , et al. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. J Diabetes Investig, 2023; 14(4):582–590; doi: 10.1111/jdi.13973